Cargando…
The Role of Urotensin-II in Obesity and Metabolic Syndrome in Pediatric Population
Background: Urotensin-II (U-II) is a short cyclic peptide that is widely recognized as one of the most potent vasoconstrictors. U-II plays a role in the pathophysiology of MS, participating in the development of essential hypertension, insulin resistance, hyperglycemia, and a proinflammatory state....
Autores principales: | Simunovic, Marko, Jukic, Andrija, Paradzik, Martina, Supe-Domic, Daniela, Stanisic, Lada, Degoricija, Marina, Hillestad, Anna Hummelvoll, Skrabic, Veselin, Bozic, Josko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870523/ https://www.ncbi.nlm.nih.gov/pubmed/35204924 http://dx.doi.org/10.3390/children9020204 |
Ejemplares similares
-
The Prevalence of Metabolic Syndrome and Cardiovascular Risk Factors in Obese Children and Adolescents in Dalmatia: A Hospital Based Study
por: Šimunović, Marko, et al.
Publicado: (2016) -
Urotensin II levels in patients with inflammatory bowel disease
por: Alicic, Damir, et al.
Publicado: (2021) -
Cataract as Early Ocular Complication in Children and Adolescents with Type 1 Diabetes Mellitus
por: Šimunović, Marko, et al.
Publicado: (2018) -
Right Ventricular Free Wall Strain and Congestive Hepatopathy in Patients with Acute Worsening of Chronic Heart Failure: A CATSTAT-HF Echo Substudy
por: Borovac, Josip A., et al.
Publicado: (2020) -
Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT‐HF study
por: Borovac, Josip A., et al.
Publicado: (2020)